Yet, immune cell restricted C/EBPβ‐deficiency did not confer protection from hepatic steatosis, inflammation and fibrosis, that are suggested to be influenced by C/EBPβ expression in nonimmune cells. Here, CEBPB is linked to fatty liver disease.